Macrogenics Inc (MGNX)
4.73
+0.03
(+0.64%)
USD |
NASDAQ |
May 23, 10:21
Macrogenics Accounts Receivable (Quarterly): 7.219M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 7.219M |
December 31, 2023 | 10.37M |
September 30, 2023 | 25.31M |
June 30, 2023 | 6.41M |
March 31, 2023 | 36.16M |
December 31, 2022 | 56.22M |
September 30, 2022 | 13.84M |
June 30, 2022 | 18.38M |
March 31, 2022 | 14.90M |
December 31, 2021 | 10.39M |
September 30, 2021 | 13.76M |
June 30, 2021 | 45.25M |
March 31, 2021 | 7.148M |
December 31, 2020 | 23.08M |
September 30, 2020 | 18.78M |
June 30, 2020 | 19.20M |
March 31, 2020 | 11.81M |
December 31, 2019 | 12.74M |
September 30, 2019 | 9.503M |
June 30, 2019 | 5.613M |
March 31, 2019 | 6.115M |
December 31, 2018 | 29.58M |
September 30, 2018 | 20.97M |
Date | Value |
---|---|
June 30, 2018 | 17.84M |
March 31, 2018 | 7.281M |
December 31, 2017 | 13.64M |
September 30, 2017 | 2.194M |
June 30, 2017 | 1.991M |
March 31, 2017 | 2.093M |
December 31, 2016 | 2.764M |
September 30, 2016 | 3.008M |
June 30, 2016 | 78.38M |
March 31, 2016 | 2.512M |
December 31, 2015 | 1.224M |
September 30, 2015 | 2.744M |
June 30, 2015 | 4.334M |
March 31, 2015 | 1.719M |
December 31, 2014 | 2.935M |
September 30, 2014 | 5.315M |
June 30, 2014 | 2.645M |
March 31, 2014 | 1.746M |
December 31, 2013 | 2.004M |
September 30, 2013 | 2.281M |
June 30, 2013 | 4.153M |
December 31, 2012 | 2.046M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
5.613M
Minimum
Jun 2019
56.22M
Maximum
Dec 2022
18.30M
Average
13.80M
Median
Accounts Receivable (Quarterly) Benchmarks
Moderna Inc | 137.00M |
Allurion Technologies Inc | 16.16M |
Novavax Inc | 21.38M |
United Therapeutics Corp | 307.30M |
MEI Pharma Inc | -- |